FdaApplication

ANDA 078819

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeANDA
approval_date2010-06-02

Products (2)

ProductActive ingredientStrengthDosage form
OXALIPLATINOXALIPLATIN100MG/VIALINJECTABLE;INTRAVENOUS
OXALIPLATINOXALIPLATIN50MG/VIALINJECTABLE;INTRAVENOUS

2 products